The firm's financial position has deteriorated significantly, evidenced by a current ratio that plummeted from 19.66 in 2024Q2 to 0.15 in 2024Q4.
| Total Current Assets | 265K | 24.86M | 42.63M | 52.75M | 18.42M | 8.44M | 14.98M | 7.4M | 11.88M | 14.93M | 6.04M | 5.15M | 8.24M |
| Cash & Short-Term Investments | 265K | 24.76M | 41.7M | 51.56M | 17.78M | 7.68M | 14.21M | 7M | 11.64M | 14.2M | 1.07M | 4.97M | 8.03M |
| Cash Only | 0 | 8.84M | 4.09M | 26.46M | 7.7M | 7.68M | 8.57M | 7M | 11.64M | 9.39M | 1.07M | 4.97M | 4.58M |
| Short-Term Investments | 265K | 15.91M | 37.61M | 25.1M | 10.08M | 0 | 5.64M | 0 | 0 | 4.81M | 0 | 0 | 3.45M |
| Accounts Receivable | 0 | 44K | 88K | 206K | 142K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Sales Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Inventory | 0 | 0 | 264K | 144K | 208K | 193K | 0 | -89K | 48K | -4.91M | 73K | 0 | 0 |
| Days Inventory Outstanding | - | - | 237.93 | 256.39 | 512.97 | 612.57 | - | - | 134.77 | - | - | - | - |
| Other Current Assets | 0 | 21K | 311K | 356K | 150K | 346K | 529K | 90K | 0 | 474K | 93K | 155K | 148K |
| Total Non-Current Assets | 112K | 161K | 2.81M | 2.91M | 1.22M | 994K | 452K | 503K | 414K | 369K | 1.75M | 224K | 256K |
| Property, Plant & Equipment | 112K | 161K | 2.81M | 2.91M | 1.22M | 994K | 452K | 503K | 414K | 369K | 191K | 224K | 256K |
| Fixed Asset Turnover | - | - | - | - | - | - | - | - | 0.59x | 0.47x | -4.13x | - | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.56M | 0 | 0 |
| Total Assets | 377K | 25.02M | 45.44M | 55.66M | 19.64M | 9.43M | 15.44M | 7.91M | 12.29M | 15.3M | 7.79M | 5.38M | 8.5M |
| Asset Turnover | - | - | - | - | - | - | - | - | 0.02x | 0.01x | -0.10x | - | - |
| Asset Growth % | -98.49% | -44.95% | -18.36% | 183.42% | 108.27% | -38.92% | 95.24% | -35.7% | -19.63% | 96.51% | 44.84% | -36.73% | - |
| Total Current Liabilities | 1.81M | 1.33M | 3.41M | 4.04M | 2.98M | 2.8M | 2.22M | 1.56M | 1.37M | 2.07M | 2.82M | 1.02M | 789K |
| Accounts Payable | 492K | 141K | 952K | 1.05M | 862K | 989K | 1.11M | 608K | 393K | 577K | 333K | 221K | 140K |
| Days Payables Outstanding | 1.12K | 242.76 | 857.98 | 1.87K | 2.13K | 3.14K | 2.74K | 1.41K | 1.1K | 2.29K | - | - | - |
| Short-Term Debt | 0 | 0 | 337K | 350K | 264K | 222K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 142K | 783K | 521K | 330K | 81K | 490K | 249K | 352K | 246K | 258K | 1.41M | 141K | 140K |
| Current Ratio | 0.15x | 18.69x | 12.51x | 13.05x | 6.18x | 3.01x | 6.75x | 4.74x | 8.69x | 7.20x | 2.14x | 5.05x | 10.44x |
| Quick Ratio | 0.15x | 18.69x | 12.43x | 13.02x | 6.11x | 2.94x | 6.75x | 4.80x | 8.66x | 9.57x | 2.11x | 5.05x | 10.44x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 16K | 0 | 721K | 927K | 279K | 393K | 185K | 439K | 521K | 577K | 2.73M | 3.16M | 2.58M |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 16K | 0 | 627K | 795K | 125K | 211K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 94K | 132K | 154K | 182K | 185K | 439K | 521K | 577K | 2.73M | 3.16M | 2.58M |
| Total Liabilities | 1.83M | 1.33M | 4.13M | 4.97M | 3.26M | 3.19M | 2.41M | 2M | 1.89M | 2.65M | 5.56M | 4.18M | 3.37M |
| Total Debt | 136K | 0 | 964K | 1.15M | 389K | 433K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Debt | 136K | -8.84M | -3.13M | -25.31M | -7.31M | -7.25M | -8.57M | -7M | -11.64M | -9.39M | -1.07M | -4.97M | -4.58M |
| Debt / Equity | - | - | 0.02x | 0.02x | 0.02x | 0.07x | - | - | - | - | - | - | - |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | -2883.22x | -1483.62x | -1669.50x | -1332.38x | -1161.00x | -1758.63x | -1580.43x | -1428.71x | -1294.57x | -265.17x | -962.00x | - | -651.33x |
| Total Equity | -1.45M | 23.69M | 41.31M | 50.69M | 16.38M | 6.23M | 13.03M | 5.91M | 10.41M | 12.65M | 2.23M | 1.19M | 5.13M |
| Equity Growth % | -106.12% | -42.66% | -18.5% | 209.51% | 162.72% | -52.16% | 120.66% | -43.26% | -17.72% | 467.94% | 86.99% | -76.78% | - |
| Book Value per Share | -0.25 | 4.05 | 7.28 | 12.24 | 10.79 | 15.61 | 64.22 | 81.17 | 172.27 | 254.70 | 44.86 | 47.91 | 206.33 |
| Total Shareholders' Equity | -1.45M | 23.69M | 41.31M | 50.69M | 16.38M | 6.23M | 13.03M | 5.91M | 10.41M | 12.65M | 2.23M | 1.19M | 5.13M |
| Common Stock | 83.75M | 83.75M | 83.66M | 68.79M | 31.65M | 5.41M | 3.46M | 974K | 771K | 599K | 53K | 53K | 53K |
| Retained Earnings | -170.01M | -144.86M | -127.29M | -108.19M | -90.98M | -77.14M | -63.3M | -52.71M | -42.94M | -34.12M | -26.56M | -22.48M | -18.49M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 | 0 | -13K | -619K | -462K | -505K | 743K | 431K | 374K |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Imminent Liquidity and Delisting
As reported in recent financial statements, the company's total assets have plummeted from $49.5 million in 2022Q3 to a mere $377.0K by 2024Q4, signaling a severe and rapid contraction that underscores the firm's inability to sustain its clinical-stage operations without significant external capital injections.
The precipitous decline in asset value suggests that the company has exhausted its primary capital reserves while failing to reach commercialization milestones. This trajectory implies that the business model is currently unsustainable, with the balance sheet reflecting a firm in the final stages of capital depletion.
Based on the most recent quarterly filings, the current ratio has deteriorated to 0.15, a stark decline from the 19.66 observed in 2024Q2, indicating that the company lacks the necessary liquid assets to cover its immediate short-term obligations and operational expenses.
The collapse in the current ratio suggests that the company's liquidity buffer has been entirely eroded, leaving it highly vulnerable to insolvency. Investors should monitor this trend as it implies an urgent need for dilutive financing or a potential cessation of core research activities.
According to the latest balance sheet data, the company's equity has shifted into a negative position of -$1.4 million as of 2024Q4, driven by the relentless accumulation of retained earnings losses which have now reached a total of -$170.0 million over the observed period.
The transition to negative equity suggests that the company has effectively wiped out its shareholder capital through persistent operational losses. This condition warrants further investigation into the firm's ability to continue as a going concern without a fundamental restructuring of its capital base.
As indicated by the provided financial data, the company's asset base is now almost entirely devoid of meaningful value, with PPE net assets shrinking to just $112.0K, which may suggest that the firm has liquidated or impaired its physical infrastructure to fund ongoing administrative costs.
The lack of tangible assets implies that the company's valuation is now entirely dependent on intangible intellectual property that has yet to be validated by commercial success. This concentration of risk suggests that any further operational delays could lead to a total loss of residual value for shareholders.
Quick answers to the most common questions about buying CHEK stock.
As of 2024, Check-Cap Ltd. (CHEK) had total assets of $0.4M including $0.3M in current assets.
Check-Cap Ltd. (CHEK) carries total debt of $0.1M, offset by $0.3M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.
Check-Cap Ltd. (CHEK) has total shareholders' equity (book value) of $-1.4M ($-0.25 book value per share). Book value represents the net worth of the company belonging to common stock holders.
Check-Cap Ltd. (CHEK) reported a current ratio of 0.15x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.